Viva Cyte Programmatūras kompleksa platforma — Livia Stevenin

Darbs Viva Cyte Programmatūras kompleksa platforma, kura autors ir Livia Stevenin, ir augsti novērtēts un ļoti prestižās 2025 Sudraba balva A' Design Award ieguvējs kategorijā Saskarnes, mijiedarbības un lietotāja pieredzes dizains.

SudrabaSaskarne· 2025

Viva Cyte Programmatūras kompleksa platforma

Autors: Livia Stevenin

Klients: Cellply

Sudraba balva A' Design Award ieguvējs kategorijā Saskarne

56,621

Verificēts balvas ieguvējs

Verificēt balvas statusu dizainam #168358

Apmeklēt vietni Skatīt A' Design Award Preses relīze Balvas žetons

Krāsas

Dizains

Par Viva Cyte Programmatūras kompleksa platforma

Viva Cyte ir progresīva programmatūras platforma, kas izstrādāta, lai racionalizētu šūnu terapijas izstrādi, integrējot automatizāciju, augsta caurlaidspējas analīzi un intuitīvu lietotāja pieredzi. Tā sastāv no vadības programmatūras (CSW) bioloģisko testu pārvaldībai un analītiskās programmatūras (ASW) nozīmīgu ieskatu iegūšanai. Mākslīgā intelekta virzīta automatizācija samazina cilvēka kļūdas, paaugstina precizitāti un uzlabo lietojamību, ļaujot pētniekiem efektīvi orientēties sarežģītos darba procesos, vienlaikus paātrinot terapijas attīstību.

Atzinība

Par Sudraba balva A' Design Award

Viva Cyte Programmatūras kompleksa platforma ir Sudraba balvas A' Design Award ieguvējs, ārkārtīgi prestiža atzinība, ko piešķir augstākās klases, krāšņiem un iespaidīgiem dizainiem. Sudraba ieguvēji ir ārkārtīgi spožas un ļoti radošas izpausmes, kas parāda to dizaineru izcilo kompetenci, talantu un asredzību. Sagaidāms, ka Viva Cyte Programmatūras kompleksa platforma būs lielisks, paraugdarbs, ļoti profesionāls un dziļi inovatīvs. Šis ar Sudraba balvu apbalvotais dizains ir ievērojams, apbrīnots izgudrojums, kas palīdz paplašināt mākslas, zinātnes, dizaina un tehnoloģiju robežas. Viva Cyte Programmatūras kompleksa platforma ir radījums, kam daudzi apskauž, kas modina vēlmes, rada pozitīvas izjūtas un raisa izbrīnu un apbrīnu.

Aiz dizaina

Preses materiāli

Dizainera sniegtie autori, komandas dalībnieki un tehniskie dati.

Unikālās īpašības: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Izmēri un iepakojums: Design: Figma
Front-end: React JS
Design System: Bento
Birkas: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Ražošanas tehnoloģija: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Dizaina izaicinājums: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Pētījums: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Iedvesma: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Projekta ilgums: The project started in January 2022 in Milan and finished in August 2024.
Darbības plūsma: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Komandas dalībnieki: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Attēlu autori: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),